Skip to search formSkip to main contentSkip to account menu

BW-33A

Known as: BW 33A, BW33A 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AtracuriumAtracurium Besylate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1983
Highly Cited
1983
Safety and Efficacy of Atracurium (BW33A) in Surgical Patients Receiving Balanced or Isoflurane Anesthesia
Atracurium was administered in a dose range of 0.027–0.4 mg/kg and dose-respone curves were established for both balanced and… 
1983
1983
Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
Comparative patterns of recovery during successive doses of three new, relatively non-cumulative, intermediate-duration non… 
1982
1982
SITE ACTION OF BW33A AT THE RAT NEUROMUSCULAR JUNCTION
1982
1982
CLINICAL PHARMACOLOGY OF ATRACURIUM (BW33A) IN PEDIATRIC PATIENTS
1982
1982
CIRCULATORY EFFECTS OF BW33A IN THE DOG
1982
1982
RELAXATION WITH BW33A UNDER NEUROLEPT AND ENFLURANE ANESTHESIA
1982
1982
NEUROMUSCULAR AND CARDIOVASCULAR EFFECTS OF BW 33A (ATRACURIUM) IN PATIENTS UNDER HALOTHANE ANESTHESIA
1982
1982
HEMODYNAMIC EFFECTS OF BW33A IN SURGICAL PATIENTS UNDERN2O - O2ISOFLURANE ANESTHESIA
1982
1982
Comparative Patterns Of Recovery Of Three New Nondepolarizing Relaxants: Bw A444u,bw 33a (atracurium) And Org Nc45 (vecuronium)
1982
1982
CLINICAL PHARMACOLOGY OF ATRACURIUM (BW 33A) IN ADOLESCENTS ANESTHETIZED WITH HALOTHANE
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)